Search Results
QUAZAR AML-001: oral azacitidine as maintenance therapy in AML
QUAZAR: Oral Azacitidine Maintenance in AML
QUAZAR AML-001: a new standard for AML maintenance therapy
Oral azacitidine maintenance in AML: QUAZAR AML-001 results after 52 months of follow-up
QUAZAR AML-001: Evaluating CC-486 as a maintenance therapy for older patients with acute myeloid...
Oral azacitidine maintenance in AML with MDS-related changes: insights from QUAZAR AML-001
Oral azacitidine maintenance therapy for post-transplant AML
The QUAZAR AML-001 Maintenance Trial (Oral Formulation of Azacitidine in AML First Remission
Oral therapies in the future of AML treatment
Why maintenance therapy in AML is unnecessary
Updates on maintenance therapies in AML
IACH Journal Club: Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in 1st Remission
